AU7484798A - Methods for treating inflammation, inflammatory diseases, arthritis and strok e using padprt inhibitors - Google Patents
Methods for treating inflammation, inflammatory diseases, arthritis and strok e using padprt inhibitorsInfo
- Publication number
- AU7484798A AU7484798A AU74847/98A AU7484798A AU7484798A AU 7484798 A AU7484798 A AU 7484798A AU 74847/98 A AU74847/98 A AU 74847/98A AU 7484798 A AU7484798 A AU 7484798A AU 7484798 A AU7484798 A AU 7484798A
- Authority
- AU
- Australia
- Prior art keywords
- strok
- arthritis
- methods
- inflammatory diseases
- treating inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/855,616 US5908861A (en) | 1997-05-13 | 1997-05-13 | Methods for treating inflammation and inflammatory disease using pADPRT inhibitors |
US08855616 | 1997-05-13 | ||
US09/056,396 US6303629B1 (en) | 1997-05-13 | 1998-04-06 | Methods for treating inflammation, inflammatory diseases, arthritis and stroke using pADPRT inhibitors |
US09056396 | 1998-04-06 | ||
PCT/US1998/009768 WO1998051307A1 (en) | 1997-05-13 | 1998-05-13 | METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7484798A true AU7484798A (en) | 1998-12-08 |
Family
ID=26735288
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74926/98A Ceased AU745790B2 (en) | 1997-05-13 | 1998-05-13 | Methods for treating inflammation and inflammatory diseases using pADPRT inhibitors |
AU74847/98A Abandoned AU7484798A (en) | 1997-05-13 | 1998-05-13 | Methods for treating inflammation, inflammatory diseases, arthritis and strok e using padprt inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74926/98A Ceased AU745790B2 (en) | 1997-05-13 | 1998-05-13 | Methods for treating inflammation and inflammatory diseases using pADPRT inhibitors |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1009404A4 (en) |
JP (1) | JP4362638B2 (en) |
CN (1) | CN1198614C (en) |
AU (2) | AU745790B2 (en) |
BR (1) | BR9809115A (en) |
CA (1) | CA2289119C (en) |
IL (1) | IL132758A0 (en) |
NZ (1) | NZ501650A (en) |
WO (2) | WO1998051307A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
OA11749A (en) | 1999-01-11 | 2005-07-19 | Agouron Pharma | Tricyclic inhibitors of poly(adp-ribose)polymerases. |
ECSP003637A (en) | 1999-08-31 | 2002-03-25 | Agouron Pharma | TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES |
ES2282410T3 (en) | 2001-05-08 | 2007-10-16 | Kudos Pharmaceuticals Limited | ISOQUINOLINONE DERIVATIVES AS PARP INHIBITORS |
DE60335359D1 (en) | 2002-04-30 | 2011-01-27 | Kudos Pharm Ltd | phthalazinone |
US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
TW200536830A (en) | 2004-02-06 | 2005-11-16 | Chugai Pharmaceutical Co Ltd | 1-(2H)-isoquinolone derivative |
TWI389897B (en) | 2005-02-22 | 2013-03-21 | Chugai Pharmaceutical Co Ltd | 1- (2H) -isoquinolinone derivatives |
RU2008100017A (en) * | 2005-06-10 | 2009-07-20 | Бипар Сайенсиз, Инк. (Us) | PARP MODULATORS AND CANCER TREATMENT METHOD |
GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
CA2662335A1 (en) * | 2006-09-05 | 2008-03-13 | Valeria Ossovskaya | Methods for designing parp inhibitors and uses thereof |
WO2008030891A2 (en) * | 2006-09-05 | 2008-03-13 | Bipar Sciences, Inc. | Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof |
CN101641013B (en) | 2007-01-22 | 2014-07-30 | Gtx公司 | Nuclear receptor binding agents |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
PT2118074E (en) | 2007-02-01 | 2014-03-20 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular diseases |
AU2008299721A1 (en) | 2007-09-14 | 2009-03-19 | Astrazeneca Ab | Phthalazinone derivatives |
UY31603A1 (en) | 2008-01-23 | 2009-08-31 | DERIVATIVES OF FTALAZINONA | |
EP2346837B8 (en) | 2008-06-26 | 2015-04-15 | Resverlogix Corporation | Methods of preparing quinazolinone derivatives |
HUE030800T2 (en) | 2008-10-07 | 2017-05-29 | Astrazeneca Uk Ltd | Pharmaceutical formulation 514 |
EP2377871A4 (en) | 2008-11-28 | 2012-07-25 | Chugai Pharmaceutical Co Ltd | 1-(2h)-isoquinolone derivative |
EP2382194B1 (en) | 2009-01-08 | 2014-03-12 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
NZ708314A (en) | 2009-03-18 | 2017-08-25 | Resverlogix Corp | Quinazolinones for use as anticancer agents |
BRPI1014956B8 (en) | 2009-04-22 | 2021-05-25 | Resverlogix Corp | anti-inflammatory agents |
PL2773354T3 (en) | 2011-11-01 | 2019-12-31 | Resverlogix Corp. | Oral immediate release formulations for substituted quinazolinones |
WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
JP2016507496A (en) | 2012-12-21 | 2016-03-10 | ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. | Novel heterocyclic compounds as bromodomain inhibitors |
JO3789B1 (en) | 2015-03-13 | 2021-01-31 | Resverlogix Corp | Compositions and therapeutic methods for the treatment of complement -associated diseases |
US11433074B2 (en) | 2017-06-22 | 2022-09-06 | Triact Therapeutics, Inc. | Methods of treating glioblastoma |
US11628144B2 (en) | 2017-09-29 | 2023-04-18 | Triact Therapeutics, Inc. | Iniparib formulations and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6518890A (en) | 1989-09-26 | 1991-04-28 | Regents Of The University Of California, The | 6-amino-1,2-benzopyrones useful for treatment of viral diseases |
US5484951A (en) | 1990-10-19 | 1996-01-16 | Octamer, Incorporated | 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents |
US5464871A (en) | 1993-05-12 | 1995-11-07 | Octamer, Inc. | Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
US5516941A (en) | 1991-10-22 | 1996-05-14 | Octamer, Inc. | Specific inactivators of "retroviral" (asymmetric) zinc fingers |
US5482975A (en) | 1991-10-22 | 1996-01-09 | Octamer, Inc. | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents |
US5473074A (en) | 1991-10-22 | 1995-12-05 | Octamer, Incorporated | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54 |
DE4436127A1 (en) | 1994-09-27 | 1996-03-28 | Deutsches Rheumaforschungszent | Use of benzoic or pyridine:carboxylic acid or amide cpds. |
AU5259296A (en) * | 1995-04-07 | 1996-10-23 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of athero sclerosis |
US10766598B2 (en) | 2017-06-14 | 2020-09-08 | The Boeing Company | Wing-to-fuselage joints and aircraft including the same |
-
1998
- 1998-05-13 NZ NZ501650A patent/NZ501650A/en not_active IP Right Cessation
- 1998-05-13 WO PCT/US1998/009768 patent/WO1998051307A1/en active Application Filing
- 1998-05-13 IL IL13275898A patent/IL132758A0/en unknown
- 1998-05-13 CN CNB988063891A patent/CN1198614C/en not_active Expired - Fee Related
- 1998-05-13 WO PCT/US1998/010033 patent/WO1998051308A1/en not_active Application Discontinuation
- 1998-05-13 JP JP54960898A patent/JP4362638B2/en not_active Expired - Fee Related
- 1998-05-13 EP EP98922359A patent/EP1009404A4/en not_active Ceased
- 1998-05-13 AU AU74926/98A patent/AU745790B2/en not_active Ceased
- 1998-05-13 AU AU74847/98A patent/AU7484798A/en not_active Abandoned
- 1998-05-13 BR BR9809115-8A patent/BR9809115A/en not_active Application Discontinuation
- 1998-05-13 CA CA2289119A patent/CA2289119C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4362638B2 (en) | 2009-11-11 |
JP2002502367A (en) | 2002-01-22 |
IL132758A0 (en) | 2001-03-19 |
EP1009404A4 (en) | 2009-07-01 |
WO1998051308A1 (en) | 1998-11-19 |
NZ501650A (en) | 2001-11-30 |
EP1009404A1 (en) | 2000-06-21 |
AU745790B2 (en) | 2002-03-28 |
CN1261278A (en) | 2000-07-26 |
CN1198614C (en) | 2005-04-27 |
CA2289119C (en) | 2011-03-15 |
AU7492698A (en) | 1998-12-08 |
CA2289119A1 (en) | 1998-11-19 |
BR9809115A (en) | 2002-01-02 |
WO1998051307A1 (en) | 1998-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7484798A (en) | Methods for treating inflammation, inflammatory diseases, arthritis and strok e using padprt inhibitors | |
AU9035498A (en) | Method for treating pain | |
IL143674A0 (en) | Metalloproteinase inhibitors, and the methods for making these | |
AU6369199A (en) | System and method for specifying www site | |
AU7383398A (en) | Therapeutic glasses and method for using the same | |
AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
AU5087199A (en) | Method of treating topical ailments | |
AU2002329022A1 (en) | Method and pharmaceutical composition for treating inflammation | |
AU6666798A (en) | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions | |
AU4499697A (en) | Method for treating parasitic diseases with proteasome inhibitors | |
AU2543097A (en) | Method for treating pain | |
AU2587297A (en) | Method for treating pain | |
AU8175498A (en) | Quinazoline analogs and related compounds and methods for treating inflammatory conditions | |
AU4713601A (en) | Method and system for treating stroke using hypothermia | |
AU5860396A (en) | Substituted oxazoles for the treatment of inflammation | |
AU3102397A (en) | Metalloprotease inhibitors | |
AU5294100A (en) | Method and compositions for treating the inflammatory response | |
AU2808997A (en) | Method for treating inflammation | |
AU3850299A (en) | Vegf activity inhibitors | |
AU7472798A (en) | Cox-2 inhibitors in combination with nmda-blockers for treating pain | |
AU8858398A (en) | Matrix metalloproteinase inhibitors | |
IL130485A0 (en) | New treatment for joint inflammation | |
AU3342297A (en) | Matrix metalloproteinase inhibitors | |
AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
AU2340897A (en) | Method for treating pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |